Medical cannabis: Knowledge and attitudes of prospective doctors in Serbia

Kusturica, Milica Paut; Tomas, Ana; Sabo, Ana; Tomić, Z.; Horvat, Olga

doi:10.1016/j.jsps.2018.11.014

Cited by 22 publications

(29 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Over 71% of physicians declared that their knowledge level about cannabinoids is “not” or “rather not” sufficient for patient counseling. Our finding that MDs self-evaluated knowledge about cannabinoids is not sufficient is repeatedly found in studies from other countries [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 ]. In Norway, 71% of surveyed physicians declared that they would like to be more knowledgeable about this topic [ 22 ].…”

Section: Discussionsupporting

confidence: 78%

“…Surveys regarding medical cannabis were conducted worldwide among certified medical doctors, pharmacists, and medical faculty students [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 ]. Most of these studies reveal problems with the lack of local clinical standards or knowledge about the legal status of medical cannabis [ 12 , 13 ].…”

Section: Introductionmentioning

confidence: 99%

“…Furthermore, both students of medical faculties, including medicine, nursing, or pharmacy, and certified physicians declare they would like to receive more education. The students participating in these studies from other European countries (Spain, Poland, Serbia) also admit that they would like to have some classes at the university [ 19 , 20 , 21 ]. Previous studies demonstrate that, although most medical doctors accept using cannabis for medical reasons, recreational uses do not get as much support.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Polish Physicians’ Perspectives on Medical Cannabis Policy and Educational Needs: Results of An Online Survey

Hordowicz

Jarosz²,

Czaplińska

et al. 2021

JCM

View full text Add to dashboard Cite

(1) Background: In November 2017, medical cannabis was legalized in Poland. Until now, there have been no studies conducted to examine the perspectives of Polish physicians about their preferences regarding medical cannabis legal status and educational needs. (2) Methods: The survey was a self-developed online questionnaire with 57 participants. Participation was voluntary. The link was shared through a personal network of medical doctors, regional medical chambers, and with doctors attending palliative care courses organized by our research group. Results: Between June and October 2020, 173 HCPs from Poland completed the survey. More than half of the study participants never received any education on medical cannabis (60.1%); 71.1% declared their knowledge was insufficient to counsel patients about medical cannabis use. The majority claimed that they would like to be able to answer patient questions (92.4%); 93.1% declared a need to create clear guidelines for using cannabinoids in clinical practice. Furthermore, 71.7% believed that medicines containing cannabinoids and 52.0% that herbal cannabis should be reimbursed (3). Conclusion: Most medical doctors do not feel prepared for patient counseling. They could benefit from targeted educational interventions. We have also identified physicians’ preferences that might inspire the stakeholders involved who are critical for shaping policies regarding cannabis-based therapeutics.

show abstract

Section: Discussionsupporting

confidence: 78%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Polish Physicians’ Perspectives on Medical Cannabis Policy and Educational Needs: Results of An Online Survey

Hordowicz

Jarosz²,

Czaplińska

et al. 2021

JCM

View full text Add to dashboard Cite

show abstract

“…One of them is the lack of knowledge among the medical profession regarding the doses, indications, and adverse effects of cannabis-based preparations (Alexander, 2020 ). In part, this is due to the limited importance that medical schools place on MC-related content (Paut Kusturica et al, 2019 ) and its possible health benefits (Karanges et al, 2018 ). Another barrier is that most doctors feel safer prescribing evidence-supported drugs, and in the case of MC, especially as it relates to the area of mental health, the evidence is limited and of low quality (Sarris et al, 2020 ).…”

Section: Introductionmentioning

confidence: 99%

“…Although the survey did not emphasize psychiatric symptoms and did not include mental health workers, the level of approval for use was 45% for anxiety, 27% for sleep disorders and 12% for depression (Philpot et al, 2019 ). Another study on the perception of MC among medical students in Serbia only considered nonpsychiatric medical indications for its use and took psychiatric symptoms such as anxiety, depression, sleep disturbances, and psychosis only as adverse effects (Paut Kusturica et al, 2019 ). Another survey of 640 Australian general practitioners revealed strong support for the use of MC for cancer pain, palliative care and epilepsy but low support for its use for depression and anxiety (Karanges et al, 2018 ).…”

Section: Introductionmentioning

confidence: 99%

Medicinal cannabis: knowledge, beliefs, and attitudes of Colombian psychiatrists

2021

View full text Add to dashboard Cite

Background The use of cannabinoids in mental health has gained strength in recent years due to emerging scientific evidence and the lifting of prohibitionist laws that prevailed for years in many countries, including Colombia. This study describes the results of a survey of Colombian psychiatrists on some aspects of medicinal cannabis, such as attitudes towards its potential use, perceived knowledge, and beliefs surrounding its regulation and safety. Methods We conducted a cross-sectional survey of 145 psychiatrists in 14 territories of Colombia between November 2019 and July 2020. The survey consisted of 28 items on topics related to medicinal cannabis, including attitudes and clinical experience (4 items), perceived knowledge (4 items), indications for use in psychiatric pathologies (6 items), indications for use in nonpsychiatric pathologies (8 items), and concerns and awareness about safety and efficacy (6 items). The results were summarized using descriptive statistics. In addition, possible associations among variables were examined using Fisher’s exact test. Results Eighty-two percent of the psychiatrists agreed that medical cannabis should be available for different medical conditions, and 73.1% stated that they wanted to be able to prescribe it. However, 66.2% said they did not know how to help their patients legally access it, and only 25% understood the legal status of medicinal cannabis in the country. The mental health indications that received the highest approval levels for cannabis use were insomnia (35.2%), anxiety disorders (29%), and agitation in dementia (18.6%). The greatest disapproval of cannabis use was indicated for schizophrenia, with 66.9%. The most approved nonpsychiatric medical conditions were cancer-related chronic pain (87.6%), chemotherapy-related nausea and vomiting (78.6%), and chronic pain not associated with cancer (72.4%). Multinomial stepwise logistic regression analysis showed that female psychiatrists who did not agree with MC to treat psychiatric symptoms were more likely to agree with non-psychiatric use. Conclusions Our results showed that this sample of Colombian psychiatrists have a favorable attitude towards the prescription of medicinal cannabis; however, there is a serious lack of knowledge of the legal status of medicinal cannabis in the country and the methods through which patients can gain access to government-regulated products. Most of them approve the use of MC for nonpsychiatric conditions and, in general, disapprove of its use in mental illnesses. They generally consider medicinal cannabis as a safe treatment compared to other psychotropic drugs and medications with potential risk of dependence, such as opioids and/or benzodiazepines.

show abstract

Healthcare professionals and medical cannabis: a scoping review informed by the theoretical domains framework

O’Rourke

Lima

Jetten

2021

J Public Health (Berl.)

View full text Add to dashboard Cite

Medical cannabis: Knowledge and attitudes of prospective doctors in Serbia

Cited by 22 publications

References 21 publications

Polish Physicians’ Perspectives on Medical Cannabis Policy and Educational Needs: Results of An Online Survey

Polish Physicians’ Perspectives on Medical Cannabis Policy and Educational Needs: Results of An Online Survey

Medicinal cannabis: knowledge, beliefs, and attitudes of Colombian psychiatrists

Healthcare professionals and medical cannabis: a scoping review informed by the theoretical domains framework

Contact Info

Product

Resources

About